Ray Dalio's WST Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 4,073 shares of West Pharmaceutical Services, Inc. (WST) worth $1.12 M, representing 0.00% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in WST, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2021, adding 39,073 shares. Largest reduction occurred in Q4 2021, reducing 75,708 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's West Pharmaceutical Services (WST) Holding Value Over Time
Track share changes against reported price movement
Quarterly West Pharmaceutical Services (WST) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +4,073 | New Buy | 4,073 | $275.14 |
| Q2 2024 | -1,292 | Sold Out | 0 | $0.00 |
| Q1 2024 | -3,101 | Reduce 70.59% | 1,292 | $395.71 |
| Q4 2023 | -262 | Reduce 5.63% | 4,393 | $352.12 |
| Q3 2023 | -280 | Reduce 5.67% | 4,655 | $375.21 |
| Q2 2023 | -30 | Reduce 0.60% | 4,935 | $382.47 |
| Q1 2023 | -7,254 | Reduce 59.37% | 4,965 | $346.47 |
| Q4 2022 | -29,858 | Reduce 70.96% | 12,219 | $235.35 |
| Q3 2022 | +18,921 | Add 81.71% | 42,077 | $246.07 |
| Q2 2022 | +12,266 | Add 112.64% | 23,156 | $302.38 |
| Q1 2022 | +2,525 | Add 30.19% | 10,890 | $410.74 |
| Q4 2021 | -75,708 | Reduce 90.05% | 8,365 | $468.98 |
| Q3 2021 | -3,495 | Reduce 3.99% | 84,073 | $424.54 |
| Q2 2021 | +39,073 | Add 80.57% | 87,568 | $359.10 |
| Q1 2021 | +6,132 | Add 14.47% | 48,495 | $281.78 |
| Q4 2020 | +24,718 | Add 140.09% | 42,363 | $283.31 |
| Q3 2020 | +17,645 | New Buy | 17,645 | $274.92 |
Ray Dalio's West Pharmaceutical Services Investment FAQs
Ray Dalio first purchased West Pharmaceutical Services, Inc. (WST) in Q3 2020, acquiring 17,645 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held West Pharmaceutical Services, Inc. (WST) for 17 quarters since Q3 2020.
Ray Dalio's largest addition to West Pharmaceutical Services, Inc. (WST) was in Q2 2021, adding 87,568 shares worth $31.45 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 4,073 shares of West Pharmaceutical Services, Inc. (WST), valued at approximately $1.12 M.
As of the Q4 2025 filing, West Pharmaceutical Services, Inc. (WST) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in West Pharmaceutical Services, Inc. (WST) was 87,568 shares, as reported at the end of Q2 2021.